GO:0006417 regulation of translation: Protein Synthesis Control, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0006417 (regulation of translation) describes any process that modulates the frequency, rate or extent of protein synthesis from mRNA or circRNA templates.
• Translational control is a rapid, energy-efficient way for cells to change protein output without altering transcript levels, and it is especially important during stress, development and infection.
• Key regulatory nodes include initiation factors such as eIF3, ribosomal proteins such as RPS7/eS7, and deubiquitinases such as OTUD6 that act on the free 40S ribosome.
• In bacteria, non-coding RNAs and nascent-chain-mediated translation arrest are major mechanisms that regulate translation and antibiotic resistance.
• Dysregulated translation is linked to cancer, ribosomopathies and neurological disease, making translational regulators attractive therapeutic targets.
• CRISPR knockout, point-mutation, knock-in and overexpression models, combined with Ribo-seq and proteomics, are standard tools for dissecting regulation of translation.
Description
Regulation of translation (GO:0006417) is the biological process that controls how often, how fast and to what extent messenger RNA or circular RNA is decoded into protein. Because translation consumes a large fraction of cellular energy, cells tightly coordinate initiation, elongation, termination and ribosome recycling to match protein production with growth, stress and developmental cues. This GO term therefore captures a central layer of gene expression control that operates downstream of transcription and upstream of protein function. For researchers, GO:0006417 is a high-value annotation because it groups diverse molecular events, from eIF3-dependent initiation to nascent-chain-mediated ribosome stalling, under a single process label. Experimental evidence in model organisms shows that translational regulation is essential for maternal mRNA utilization during early embryogenesis, for bacterial adaptation to antibiotics, and for maintaining proteostasis under stress. Consequently, genes annotated to this term are frequent candidates in cancer, infection and developmental studies. This article summarizes the QuickGO definition, the major mechanistic stages, the key genes and proteins involved, disease links, and the CRISPR and omics methods used to study regulation of translation.
regulation of translation At A Glance
| GO ID | GO:0006417 |
|---|---|
| GO term | regulation of translation |
| Ontology | biological_process |
| Definition | Any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. |
| Synonyms | regulation of protein anabolism; regulation of protein biosynthesis; regulation of protein formation; regulation of protein synthesis |
| Major function | Controls the rate and extent of protein synthesis from mRNA or circRNA templates. |
| Biological context | Operates during development, stress responses, infection and tumorigenesis. |
| Key molecular players | eIF3, RPS7/eS7, OTUD6, non-coding RNAs and nascent polypeptide chains. |
| Research relevance | A central node for cancer, ribosomopathy, neurodegeneration and antibiotic-resistance research. |
What Is GO:0006417?
GO:0006417, regulation of translation, is defined by QuickGO as any process that modulates the frequency, rate or extent of the chemical reactions and pathways resulting in the formation of proteins by the translation of mRNA or circRNA. In practical terms, it covers every layer of control over protein synthesis, including changes in translation initiation, elongation, termination, ribosome availability and mRNA accessibility. It is a biological_process term and is synonymous with regulation of protein anabolism, regulation of protein biosynthesis, regulation of protein formation and regulation of protein synthesis.
Why Is regulation of translation Important in Cell Biology?
Regulation of translation is important because it determines the final protein output of the genome and allows cells to respond rapidly to stress, nutrients, infection and developmental signals without waiting for new transcription. Defects in this process are directly implicated in cancer, where eIF3 and ribosomal proteins influence proliferation and survival, and in bacterial antibiotic resistance, where non-coding RNAs and nascent-chain stalling reprogram translation. Because translational control is fast and reversible, it is also a prime target for therapeutic intervention and a rich source of biomarkers.
• Controls the rate and extent of protein synthesis, the final step of gene expression.
• Enables rapid cellular responses to stress, nutrients and infection without new transcription.
• Essential for maternal mRNA translation and early embryonic development.
• Mediates antibiotic resistance in bacteria through non-coding RNAs.
• Involves nascent-chain-mediated translation arrest and ribosome destabilization in bacteria.
• Linked to cancer through eIF3 and ribosomal protein regulation.
• Regulates global protein synthesis via OTUD6 deubiquitination of RPS7/eS7 on the free 40S ribosome.
• Provides targets for ribosomopathy and neurodegeneration research.
• A key layer of post-transcriptional gene regulation in all domains of life.
• Amenable to CRISPR perturbation and Ribo-seq-based functional dissection.
What Happens During regulation of translation?
Initiation control
In simple terms: Initiation is the starting gate of protein synthesis, and cells often speed up or slow down translation by opening or closing this gate.
Translation initiation is a major regulatory step in GO:0006417, where eIF3 and other initiation factors assemble the 40S and 60S ribosomal subunits on an mRNA. In cancer, altered eIF3 levels change the efficiency of initiation and thereby the protein output of specific mRNAs. In C. elegans embryos, maternal Wnt mRNA translation is regulated at the initiation stage to control early developmental patterning.
Elongation and nascent-chain surveillance
In simple terms: Elongation is the assembly line, and the newly made protein chain can itself signal the ribosome to pause or stop.
During elongation, nascent polypeptide chains can mediate translation arrest and intrinsic ribosome destabilization, providing a feedback mechanism that regulates translation in bacteria. This nascent-chain-mediated control is part of GO:0006417 because it modulates the rate and extent of protein formation. Such surveillance helps cells avoid producing toxic or misfolded proteins.
Ribosome availability and 40S regulation
In simple terms: Ribosomes are the machines that make proteins, and changing how many free 40S subunits are available changes how much translation happens.
OTUD6 deubiquitinates RPS7/eS7 on the free 40S ribosome, and this modification regulates global protein translation and the stress response. This demonstrates that ribosomal protein post-translational modifications are integral to GO:0006417. The free 40S subunit pool therefore acts as a regulatory hub for translation.
Non-coding RNA control in bacteria
In simple terms: Small RNA molecules can stick to messages and block or enhance their translation, especially in bacteria.
Non-coding RNAs regulate antibiotic resistance by controlling translation in bacteria, linking GO:0006417 to clinically important phenotypes. These RNAs modulate the frequency and extent of protein synthesis from specific mRNAs. This makes bacterial translation a model system for studying RNA-based regulation.
Developmental and maternal mRNA regulation
In simple terms: In embryos, stored messages must be translated at the right time and place, and this timing is controlled by translational regulation.
Regulation of maternal Wnt mRNA translation in C. elegans embryos is required for correct developmental patterning. This illustrates how GO:0006417 operates in a developmental context to control when and where proteins are made. Such regulation is essential before the embryo can transcribe its own genome.
Key Genes Involved in GO:0006417 regulation of translation
The following genes and proteins are experimentally implicated in regulation of translation (GO:0006417) based on the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| EIF3 | Translation initiation factor complex that regulates 40S/60S assembly on mRNA | Cancer-related translation initiation and protein synthesis control |
| RPS7/eS7 | 40S ribosomal protein whose deubiquitination regulates global translation | Stress response and ribosome availability studies |
| OTUD6 | Deubiquitinase that removes ubiquitin from RPS7/eS7 on the free 40S ribosome | Global protein translation and stress regulation |
| Wnt (maternal mRNA) | Maternal transcript whose translation is regulated in early embryos | Developmental patterning and maternal mRNA control |
| Non-coding RNAs (bacterial) | Regulate antibiotic resistance by modulating translation | Bacterial translation control and drug resistance |
| Nascent polypeptide chains | Mediate translation arrest and ribosome destabilization | Bacterial translation regulation and ribosome quality control |
| eIF3 subunits | Modulate initiation efficiency for specific mRNAs | Cancer and translational reprogramming |
| 40S ribosomal subunit | Platform for initiation and RPS7/eS7 modification | Global translation and stress studies |
| 60S ribosomal subunit | Joins 40S to form the 80S elongation complex | Translation initiation and elongation research |
| mRNA templates | Provide the coding sequence decoded during translation | Targets for translational control studies |
| circRNA templates | Can be translated and are subject to regulation | Non-canonical translation research |
| Ribosome recycling factors | Recycle ribosomes after termination to sustain translation | Global translation efficiency studies |
| Stress-responsive translation factors | Reprogram translation under stress | Stress biology and proteostasis |
| Antibiotic-resistance ncRNAs | Modulate translation of resistance genes | Infectious disease and microbiology |
| Developmental translation regulators | Control timing of maternal mRNA translation | Embryogenesis and developmental biology |
How Is regulation of translation Regulated?
Regulation of translation (GO:0006417) is itself regulated at multiple levels. In cancer, eIF3 availability and modification change the efficiency of translation initiation, thereby altering the protein synthesis landscape. In stress conditions, OTUD6 deubiquitination of RPS7/eS7 on the free 40S ribosome adjusts global translation. In bacteria, non-coding RNAs and nascent-chain-mediated arrest provide feedback control over translation in response to antibiotics and folding stress. In embryos, maternal Wnt mRNA translation is temporally regulated to coordinate development. Together, these layers ensure that protein synthesis matches cellular needs.
regulation of translation and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| EIF3 | Cancer and translational reprogramming | Knockout and overexpression in cancer cell lines |
| RPS7/eS7 | Ribosomopathy and stress response | Point-mutation and tagged knock-in models |
| OTUD6 | Global translation and stress regulation | Knockout and overexpression models |
| Bacterial ncRNAs | Antibiotic resistance | Bacterial knockout and reporter assays |
| Maternal Wnt mRNA | Developmental patterning defects | Embryonic knockdown and translation reporter models |
Cancer and translational reprogramming
Cancer cells frequently reprogram translation to support proliferation and survival, and eIF3 is a key node in this process. Altered regulation of translation can change the abundance of oncoproteins and tumor suppressors without changes in mRNA levels. Targeting translation initiation is therefore an active area of cancer research.
Ribosomopathies and stress-related disease
Ribosomal protein modifications such as OTUD6-mediated deubiquitination of RPS7/eS7 regulate global translation and stress responses, linking GO:0006417 to ribosome dysfunction and stress-related disease. Defects in these pathways can impair proteostasis and cell survival.
Bacterial antibiotic resistance
Non-coding RNAs regulate antibiotic resistance by controlling translation in bacteria, making GO:0006417 directly relevant to infectious disease. Nascent-chain-mediated translation arrest and ribosome destabilization further shape bacterial adaptation. These mechanisms are potential targets for new antimicrobial strategies.
Developmental disorders
Regulation of maternal Wnt mRNA translation in C. elegans embryos is required for normal development, indicating that translational control defects can disrupt embryogenesis. Such findings support a role for GO:0006417 in developmental disorders.
From regulation of translation-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of an initiation factor change global translation? | CRISPR knockout of EIF3 subunits followed by polysome profiling |
| Does a ribosomal protein modification alter stress response? | Point mutation or knock-in of RPS7/eS7 |
| Does a deubiquitinase regulate translation? | OTUD6 knockout and overexpression |
| Is a maternal mRNA translationally controlled? | Developmental reporter and knockdown models |
| Do non-coding RNAs control antibiotic resistance? | Bacterial knockout and translation reporter assays |
| Does nascent-chain stalling regulate ribosome stability? | Bacterial genetics and ribosome profiling |
How to Study the regulation of translation Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Ribo-seq | Ribosome occupancy and translation efficiency | Global translation profiling |
| Polysome profiling | Number of ribosomes per mRNA | Initiation and elongation studies |
| Proteomics | Protein abundance and synthesis rates | Functional output of translation |
| Reporter assays | Translation of specific mRNAs | Developmental and bacterial translation |
| Imaging | Subcellular localization of translation | Ribosome and stress granule studies |
| RIP-seq / CLIP | RNA binding by translation regulators | Non-coding RNA target discovery |
| CRISPR screens | Genes required for translation phenotypes | Functional genomics of translation |
Ribosome profiling (Ribo-seq)
Ribo-seq measures ribosome occupancy on mRNAs and provides a genome-wide readout of translation efficiency, making it a core method for studying GO:0006417. It can reveal changes in initiation, elongation and stalling.
Polysome profiling
Polysome profiling separates mRNAs by the number of ribosomes bound, giving a direct measure of translation activity. It is often used to validate Ribo-seq findings and to study initiation factor function.
Proteomics and pulse labeling
Mass spectrometry and metabolic labeling quantify newly synthesized proteins and reveal the functional output of translational regulation. These approaches complement transcript-level measurements.
Reporter assays and imaging
Luciferase or fluorescent reporters, including developmental reporters, allow real-time monitoring of translation of specific mRNAs. Imaging of tagged ribosomal proteins can reveal subcellular translation dynamics.
How CRISPR Can Be Used to Study GO:0006417 regulation of translation
Knockout
CRISPR knockout of translation regulators such as EIF3 subunits or OTUD6 allows researchers to test whether a gene is required for global or mRNA-specific translation. Knockout models are typically validated by Ribo-seq and polysome profiling.
Point Mutation
Point mutations can be introduced into ribosomal protein genes such as RPS7/eS7 to dissect the function of specific residues in translation regulation. Such models help distinguish catalytic and regulatory functions.
Knock-in
Tagged knock-in of translation factors or ribosomal proteins enables imaging and biochemical purification of translation complexes. Knock-in reporters can also monitor translation of specific mRNAs in vivo.
Overexpression
Overexpression of initiation factors such as eIF3 or of OTUD6 can reveal gain-of-function effects on translation and stress responses. These models are useful for cancer and stress biology studies.
How EDITGENE Supports regulation of translation Research
Researchers studying regulation of translation-related genes often need to determine whether a candidate gene is causally involved in controlling protein synthesis, and CRISPR-based models provide a direct way to test this. By combining knockout, point-mutation, knock-in and overexpression strategies with Ribo-seq and proteomics, it becomes possible to link specific genes to translational phenotypes.
Contact EDITGENE today to design your custom CRISPR model for regulation of translation research.
Frequently Asked Questions About regulation of translation
What is GO:0006417 regulation of translation?
GO:0006417 is a Gene Ontology biological_process term defined as any process that modulates the frequency, rate or extent of protein formation by translation of mRNA or circRNA.
What genes are involved in regulation of translation?
Key genes include EIF3, RPS7/eS7, OTUD6, maternal Wnt mRNA and bacterial non-coding RNAs, as shown in the literature.
How is translation regulated in cancer?
Cancer cells reprogram translation partly through eIF3-dependent initiation control, which changes protein output without altering mRNA levels.
What is the role of OTUD6 in translation?
OTUD6 deubiquitinates RPS7/eS7 on the free 40S ribosome and thereby regulates global protein translation and stress responses.
How do non-coding RNAs regulate translation in bacteria?
Non-coding RNAs modulate translation of specific mRNAs and can control antibiotic resistance phenotypes.
What is nascent-chain-mediated translation arrest?
It is a bacterial mechanism in which the newly synthesized polypeptide chain causes translation arrest and intrinsic ribosome destabilization, regulating translation.
How can I study regulation of translation in the lab?
Common methods include Ribo-seq, polysome profiling, proteomics, reporter assays and CRISPR screens.
Which CRISPR model is best for translation studies?
The choice depends on the question: knockout for loss-of-function, point mutation for residue-level analysis, knock-in for tagging and reporters, and overexpression for gain-of-function.
Is regulation of translation important in development?
Yes, maternal Wnt mRNA translation in C. elegans embryos is regulated and is required for normal development.
What diseases are linked to regulation of translation?
Cancer, ribosomopathies, stress-related disease, bacterial antibiotic resistance and developmental disorders have been linked to translational control.
Conclusion
GO:0006417 regulation of translation is a central biological process that controls the final step of gene expression, integrating signals from development, stress, infection and disease. Its molecular players, including eIF3, RPS7/eS7, OTUD6 and non-coding RNAs, provide tractable targets for functional studies. CRISPR-based knockout, point-mutation, knock-in and overexpression models, combined with Ribo-seq and proteomics, offer a powerful toolkit for dissecting this process. As translational control emerges as a key layer in cancer, ribosomopathies and infectious disease, precise models and quantitative methods will be essential for translating mechanistic insights into therapeutic strategies.
References
- 3. Oldenbroek M et al.. 2013. Regulation of maternal Wnt mRNA translation in C. elegans embryos.. Development 140(22):4614-23 PMID: 24131629
- 4. Dar D et al.. 2017. Regulation of antibiotic-resistance by non-coding RNAs in bacteria.. Curr Opin Microbiol 36:111-117 PMID: 28414973
- 5. Villa S et al.. 2024. OTUD6 deubiquitination of RPS7/eS7 on the free 40 S ribosome regulates global protein translation and stress.. Nat Commun 15(1):6873 PMID: 39127721
- 7. Chiba S et al.. 2023. Nascent chain-mediated translation regulation in bacteria: translation arrest and intrinsic ribosome destabilization.. J Biochem 173(4):227-236 PMID: 36722132
- 8. Hershey JW. 2010. Regulation of protein synthesis and the role of eIF3 in cancer.. Braz J Med Biol Res 43(10):920-30 PMID: 20922269
